Lung Transplant clinical trials at UCSF
5 in progress, 3 open to eligible people
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
open to eligible people ages 18 years and up
The objective of the trial is to assess efficacy and safety of add-on aerosolized liposomal cyclosporine A (L-CsA) to Standard of Care (SoC) therapy as compared to SoC therapy alone in the treatment of Bronchiolitis obliterans syndrome (BOS) in single lung transplant recipients.
San Francisco, California and other locations
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
open to eligible people ages 18 years and up
The objective of the trial is to assess efficacy and safety of add-on aerosolized liposomal cyclosporine A (L-CsA) to Standard of Care (SoC) therapy as compared to SoC therapy alone in the treatment of Bronchiolitis obliterans syndrome (BOS) in double lung transplant recipients.
San Francisco, California and other locations
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
open to eligible people ages 18 years and up
Single-arm, prospective, multi-center, post-approval U.S. registry
San Francisco, California and other locations
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
Sorry, accepting new patients by invitation only
The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.
San Francisco, California and other locations
Long Term Follow up of the LTOG Cohort
Sorry, accepting new patients by invitation only
The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.
San Francisco, California and other locations
Our lead scientists for Lung Transplant research studies include Jonathan Singer, MD Steven Hays, MD Jasleen Kukreja, MD.
Last updated: